Literature DB >> 7753119

Quantitative measurement of cutaneous perception in diabetic neuropathy.

A I Vinik1, S Suwanwalaikorn, K B Stansberry, M T Holland, P M McNitt, L E Colen.   

Abstract

To determine the diagnostic value of various cutaneous sensory modalities in diabetic neuropathy, we studied cutaneous perception at the dominant hallux of 113 subjects (32 normal healthy controls and 81 diabetic subjects). The cutaneous sensory perception tests included warm and cold thermal perception, vibration, touch-pressure sensation, and current perception testing (CPT). The sensitivity of each modality when specificity is held greater than 90% was as follows: warm = 78%, cold = 77%, vibration = 88%, tactile-pressure = 77%, 5-Hz CPT = 52%, 250-Hz CPT = 48%, and 2000-Hz CPT = 56%. Combination thermal and vibratory gave optimum sensitivity (92-95%) and specificity (77-86%). We conclude that vibratory and thermal testing should be the primary screening tests for diabetic peripheral neuropathy. Other modalities may be of use only in specific situations.

Entities:  

Mesh:

Year:  1995        PMID: 7753119     DOI: 10.1002/mus.880180603

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  24 in total

1.  Reduced plantar sensitivity alters postural responses to lateral perturbations of balance.

Authors:  Peter F Meyer; Lars I E Oddsson; Carlo J De Luca
Journal:  Exp Brain Res       Date:  2004-03-17       Impact factor: 1.972

2.  The role of plantar cutaneous sensation in unperturbed stance.

Authors:  Peter F Meyer; Lars I E Oddsson; Carlo J De Luca
Journal:  Exp Brain Res       Date:  2004-02-14       Impact factor: 1.972

Review 3.  Diabetic neuropathy in older adults.

Authors:  Kara A Witzke; Aaron I Vinik
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

4.  Effect of reduced cutaneous cues on motion perception and postural control.

Authors:  Yongwoo Yi; Sukyung Park
Journal:  Exp Brain Res       Date:  2009-04-29       Impact factor: 1.972

Review 5.  Diabetic neuropathy in older adults.

Authors:  Aaron I Vinik; Elsa S Strotmeyer; Abhijeet A Nakave; Chhaya V Patel
Journal:  Clin Geriatr Med       Date:  2008-08       Impact factor: 3.076

6.  Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate.

Authors:  Amanda Boyd; Carolina Casselini; Etta Vinik; Aaron Vinik
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

7.  Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes.

Authors:  Viktor R Drel; Pal Pacher; Igor Vareniuk; Ivan A Pavlov; Olga Ilnytska; Valeriy V Lyzogubov; Seth R Bell; John T Groves; Irina G Obrosova
Journal:  Int J Mol Med       Date:  2007-12       Impact factor: 4.101

Review 8.  Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.

Authors:  Irina G Obrosova
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

9.  Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy.

Authors:  Sébastien Talbot; Emna Chahmi; Jenny Pena Dias; Réjean Couture
Journal:  J Neuroinflammation       Date:  2010-06-29       Impact factor: 8.322

10.  Balance training reduces falls risk in older individuals with type 2 diabetes.

Authors:  Steven Morrison; Sheri R Colberg; Mira Mariano; Henri K Parson; Arthur I Vinik
Journal:  Diabetes Care       Date:  2010-01-22       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.